Saroja Pharma Industries India Ltd

NSE: SAROJA

₹32.30

0.00 (0.00%)

As on 12-Jun-2026 09:07IST

Market cap

info icon

₹13 Cr

Revenue (TTM)

info icon

₹54 Cr

P/E Ratio

info icon

8

P/B Ratio

info icon

0.8

Div. Yield

info icon

0 %

Saroja Pharma Ind Share Price

Compare

High:loading Low:loading Return: loading

Max:loading Min:loading Median:loading

Max:loading Min:loading Median:loading

loading...
loading...
loading...
loading...
loading...
loading...
loading...
loading...

Stock Range

Today’s Range

Low: 0.00 High: 0.00

52 Week Range

Low: 0.00 High: 60.00

Liquidityliquidity Low

Low Moderate High

Fundamentals

  • Net Profit (TTM)Net Profit (TTM) information

    ₹1 Cr

  • ROEROE information

    6.8 %

  • ROCEROCE information

    12.6 %

  • Industry P/EIndustry P/E information

    25.87

  • EV/EBITDAEV/EBITDA information

    5.8

  • Debt to EquityDebt to Equity information

    0.6

  • Book ValueBook Value information

    ₹39

  • EPSEPS information

    ₹2.6

  • Face valueFace value information

    10

  • Shares outstandingShares outstanding information

    4,020,486

5 Years Aggregate

CFO

₹-0.35 Cr

EBITDA

₹11.47 Cr

Net Profit

₹4.84 Cr

Performance

Company
YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
Saroja Pharma Ind
-19.3 -- -3.4 -17.5 -- -- --
BSE Commodities
6.1 -1.4 7.2 9.1 16.2 10.1 15.4
As on 12-Jun-2026
Company
2025
2024
Saroja Pharma Ind
-31.4 13.1
BSE Small Cap
-6.6 29.0
BSE Commodities
12.5 8.1

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details
loading...

*All values are in (₹ Cr)

loading...

*All values are in (₹ Cr)

loading...

*All values are in (₹ Cr)

Key Ratios

View Details
loading...

loading...

loading...

5Y Avg -- 3Y Avg -- TTM --

loading...

P/E Ratio

--

--Min --Median --Max

loading...

P/B Ratio

--

--Min --Median --Max

loading...

Earnings Yield (%)

--

Earnings Yield (%) = EBIT / Enterprise value

PEG Ratio

--

Price = Price / Earnings to growth ratio

loading...

loading...

loading...

Peers

View Details
Company
Price (₹) Market Cap (₹ Cr) Revenue (TTM) Net Profit (TTM) OPM (%) ROE (%) P/E P/B
Saroja Pharma Ind
32.3 13.0 53.7 1.0 -- 6.8 8 0.8
8.5 391.0 342.9 6.0 2.7 11.7 65.3 7.2
120.4 55.4 59.3 -0.6 -7.6 0.1 -- 1.1
9.7 23.9 67.5 1.2 -0.1 9.9 19.7 1.8
221.0 139.6 18.8 18.0 4.8 3.9 7.8 0.3
IGC
2.3 7.8 0.0 -2.9 -- -- -- 0.2
16.9 26.1 0.6 -7.3 -207.7 -- -- -0.4
28.7 9.4 9.6 0.4 4.8 14.2 24.8 5.8
103.1 713.2 32.0 20.7 -13.8 0.8 34.4 0.3
244.6 446.1 652.4 16.5 1.7 12.8 27 3.4

Shareholding Pattern

View Details
loading...
These are advertorial stories which keeps Value Research free for all. Click here to mark your interest for an ad-free experience in a paid plan

News & Analysis

All News

No Review & Analysis are available.

About Saroja Pharma Ind

Pharma APIs

  • Incorporated

    2019

  • Chairman

    Biju Nair

  • Managing Director

    Biju Nair

  • Headquarters

    Mumbai, Maharashtra

  • Website

    www.sarojapharma.com

Edit peer-selector-edit
loading...
loading...

Announcements

View Announcements

No News & Announcements are available.

FAQs for Saroja Pharma Ind

The share price of Saroja Pharma Industries India Ltd is ₹32.30 (NSE) as of 12-Jun-2026 09:07 IST. Saroja Pharma Industries India Ltd has given a return of -17.5% in the last 1 years.

The P/E ratio of Saroja Pharma Industries India Ltd is 8.03 times as on 11-Jun-2026, a 69 discount to its peers’ median range of 25.87 times.
The P/B ratio of Saroja Pharma Industries India Ltd is 0.83 times as on 11-Jun-2026, a 55 discount to its peers’ median range of 1.84 times.


PE & PB ratio at the end of financial year.


Year P/E Ratio P/B Ratio
2025
14.68
0.97
2024
16.07
0.96
2023
0.00
0.00
2022
0.00
0.00
2021
0.00
0.00

The 52-week high and low of Saroja Pharma Industries India Ltd are Rs 60.00 and Rs 0.00 as of 15-Jun-2026.

Saroja Pharma Industries India Ltd has a market capitalisation of ₹ 13 Cr as on 11-Jun-2026. As per SEBI classification, it is a Small Cap company.

Before investing in Saroja Pharma Industries India Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.
Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.